SCHEMBL1827909

SCHEMBL1827909

[C]1NC=C2C=CC=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2051532 0.60
SCHEMBL2962435 0.60
SCHEMBL8973287 0.60
SCHEMBL27974613 0.58
SCHEMBL26292 0.57
SCHEMBL2047040 0.55
SCHEMBL8467152 0.54
SCHEMBL28952826 0.54
SCHEMBL28838747 0.54
SCHEMBL8466052 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318363-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS Nuevolution A/S (DK) 2011-05-11 EP claimed
WO-2009152824-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2009-12-23 WO claimed
CN-107531709-B Beta-lactamase inhibitor and use thereof 吉林四环制药有限公司 2020-10-23 CN disclosed